Rohto Pharmaceutical Co.,Ltd. (RPHCF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Rohto Pharmaceutical Co.,Ltd. (RPHCF) trades at $15.00 with AI Score 47/100 (Grade C). Rohto Pharmaceutical Co. , Ltd. is a leading manufacturer of pharmaceutical products, cosmetics, and functional foods based in Osaka, Japan. Market cap: $3.39B, Sector: Consumer defensive.
Last analyzed: Mar 17, 2026Analyst Coverage for RPHCF: RPHCF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates RPHCF against Consumer Defensive peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
RPHCF: the 1 perspectives are evenly split.
Rohto Pharmaceutical Co.,Ltd. (RPHCF) Consumer Business Overview
Rohto Pharmaceutical Co., Ltd. stands out in the consumer defensive sector with a robust portfolio of eye care, facial care, and internal medicine products, supported by a strong market presence and innovative offerings that cater to evolving consumer needs.
What Is the Investment Thesis for RPHCF?
Rohto Pharmaceutical Co., Ltd. presents a solid investment thesis driven by its diverse product offerings and strong financial metrics. With a market capitalization of $3.43 billion and a P/E ratio of 15.81, the company demonstrates a profit margin of 10.3% and a gross margin of 56.1%. Key growth catalysts include the increasing demand for eye care products and the expansion of its cosmetic line, particularly in emerging markets. The company's established brand reputation and commitment to quality enhance its competitive positioning. However, potential risks include fluctuations in raw material costs and regulatory challenges in different markets, which could impact profitability. Overall, Rohto's strategic initiatives and market adaptability position it well for sustained growth.
Based on FMP financials and quantitative analysis
RPHCF Key Highlights
- Market capitalization of $3.43 billion indicates a strong market presence.
- P/E ratio of 15.81 suggests reasonable valuation relative to earnings.
- Profit margin of 10.3% reflects effective cost management and operational efficiency.
- Gross margin of 56.1% exceeds industry averages, showcasing product pricing power.
- Dividend yield of 1.70% offers a return to shareholders amidst growth initiatives.
Who Are RPHCF's Competitors?
RPHCF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CBCFF Calbee, Inc. | $23.00 | +0.00% | $2.80B | 48 |
| CRWKF Cranswick plc | $69.05 | +0.00% | $3.70B | 48 |
| FACYF Fancl Corporation | $17.45 | +0.00% | $2.37B | 63 |
| LIOPY Lion Corporation | $16.40 | +0.00% | $2.27B | 53 |
| MRRTY Marfrig Global Foods S.A. | $3.42 | -4.20% | $2.86B | — |
| SGI Somnigroup International Inc | $72.67 | +0.48% | $15.28B | 62 |
| ELF e.l.f. Beauty, Inc. | $61.15 | +0.77% | 4B | 59 |
| MIOFF Milbon Co., Ltd. | $52.60 | +0.00% | $1.71B | 58 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RPHCF's Key Strengths?
- Strong brand reputation and consumer trust in product quality.
- Diverse product offerings catering to various health and beauty needs.
- Robust financial performance with strong margins and growth potential.
- Established global distribution network enhancing market reach.
What Are RPHCF's Weaknesses?
- Dependence on certain markets for a significant portion of revenue.
- Potential vulnerability to regulatory changes in the pharmaceutical industry.
- Limited brand recognition compared to larger multinational competitors.
- Challenges in scaling operations in emerging markets.
What Could Drive RPHCF Stock Higher?
- Launch of new eye care products targeting the growing market for vision health.
- Expansion of e-commerce platforms to increase market reach and sales.
- Development of innovative cosmetic products to meet consumer demand.
- Strategic partnerships with retailers to enhance distribution channels.
- Commitment to sustainability initiatives to attract eco-conscious consumers.
What Are the Key Risks for RPHCF?
- Regulatory changes affecting product approvals and market access.
- Fluctuations in raw material prices impacting production costs.
- Increased competition from both established and emerging brands.
- Changing consumer preferences requiring rapid adaptation.
What Are the Growth Opportunities for RPHCF?
- Expansion of Eye Care Product Line: The global eye care market is projected to reach $18 billion by 2027, with increasing consumer awareness about eye health. Rohto's established reputation in eye care products positions it to capture a significant share of this growing market, particularly through innovative formulations and targeted marketing strategies.
- Growth in E-commerce Sales: The shift towards online shopping is accelerating, with e-commerce sales in the personal care sector expected to grow by 20% annually. Rohto can leverage this trend by enhancing its online presence and distribution channels, reaching a broader audience and increasing sales.
- Emerging Markets Penetration: Emerging markets present a substantial growth opportunity, with rising disposable incomes and increasing demand for personal care products. Rohto's strategy to expand its footprint in Asia and other developing regions can drive revenue growth and market share.
- Innovative Product Development: Rohto's commitment to research and development allows it to introduce new and innovative products that meet changing consumer preferences. This focus on innovation can help the company maintain its competitive edge and attract new customers.
- Sustainability Initiatives: As consumers increasingly prioritize sustainability, Rohto's efforts to develop eco-friendly products and practices can enhance brand loyalty and attract environmentally conscious consumers, contributing to long-term growth.
What Opportunities Does RPHCF Have?
- Expansion into emerging markets with growing demand for personal care products.
- Increased focus on e-commerce sales to capture online shopping trends.
- Development of innovative products to meet evolving consumer preferences.
- Sustainability initiatives to attract environmentally conscious consumers.
What Threats Does RPHCF Face?
- Intense competition from established and emerging players in the industry.
- Fluctuations in raw material costs impacting production expenses.
- Regulatory challenges that could affect product approvals and sales.
- Changing consumer preferences that may require rapid adaptation.
What Are RPHCF's Competitive Advantages?
- Strong brand recognition in the pharmaceutical and personal care sectors.
- Diverse product portfolio catering to various consumer needs and preferences.
- Established distribution channels across multiple geographic markets.
- Commitment to research and development driving innovation and product quality.
- Customer loyalty fostered through effective marketing and high-quality offerings.
What Does RPHCF Do?
Founded in 1899, Rohto Pharmaceutical Co., Ltd. has evolved from its origins as Yamada Pharmaceutical to become a prominent player in the global pharmaceutical and personal care industry. Based in Osaka, Japan, the company rebranded to its current name in September 1949, reflecting its commitment to innovation and quality. Rohto specializes in manufacturing and marketing a wide array of products, including eye care solutions like eye drops and contact lens care, as well as facial care items such as cleansers, lotions, and creams. The company also offers a variety of internal medicines, including digestive aids and herbal remedies, along with non-prescription medications. Rohto has established a significant global footprint, distributing its products across various markets and adapting to local consumer preferences. The company’s dedication to research and development has enabled it to maintain a competitive edge in a fast-evolving industry, positioning itself as a trusted brand in health and beauty.
What Products and Services Does RPHCF Offer?
- Manufacture and market pharmaceutical products, including prescription and non-prescription medicines.
- Offer a diverse range of eye care products, such as eye drops and contact lens solutions.
- Provide facial care products, including cleansers, lotions, and creams.
- Develop functional foods and dietary supplements for health and wellness.
- Operate beauty counters that offer personalized beauty and health services.
How Does RPHCF Make Money?
- Generate revenue through the sale of pharmaceuticals, cosmetics, and functional foods.
- Leverage brand reputation to command premium pricing for quality products.
- Utilize a distribution network that includes both online and physical retail channels.
- Engage in research and development to innovate and expand product offerings.
- Capitalize on partnerships with healthcare professionals and retailers to enhance market reach.
What Industry Does RPHCF Operate In?
The household and personal products industry is experiencing steady growth, driven by increasing consumer awareness of health and wellness. The global market for personal care products is projected to expand significantly, with a compound annual growth rate (CAGR) of approximately 5% over the next five years. Rohto Pharmaceutical Co., Ltd. is well-positioned within this landscape, competing with peers such as CBCFF, CRWKF, FACYF, LIOPY, and MRRTY. The company's focus on innovative product development and responsiveness to consumer trends enhances its competitive advantage in a crowded marketplace.
Who Are RPHCF's Key Customers?
- Health-conscious consumers seeking effective pharmaceutical solutions.
- Individuals looking for quality personal care and beauty products.
- Retailers and pharmacies that stock Rohto's diverse product range.
- E-commerce platforms facilitating online sales of Rohto products.
- Beauty and health service seekers utilizing Rohto's beauty counters.
RPHCF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2026
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in Rohto's future, as executives are investing their own capital.
- Community sentiment has shifted positively, with discussions highlighting innovative product launches that could drive growth.
- The pharmaceutical sector is experiencing increased demand, and Rohto's diverse portfolio positions it well to capitalize on this trend.
- Market perception is improving due to favorable regulatory developments that may enhance Rohto's market access.
Bear Case
- Despite recent optimism, some analysts express concerns over potential supply chain disruptions affecting product availability.
- Social sentiment has shown mixed reviews, with some community members questioning the sustainability of Rohto's recent growth.
- Increased competition in the pharmaceutical space could pressure Rohto's market share and profitability moving forward.
- Recent reports indicate potential challenges in maintaining profit margins due to rising costs in production and logistics.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
RPHCF Latest News
-
Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders
Yahoo! Finance: RPHCF News · May 7, 2026
RPHCF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for RPHCF.
Price Targets
Wall Street price target analysis for RPHCF.
RPHCF MoonshotScore
What does this score mean?
The MoonshotScore rates RPHCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Hidetoshi Segi
CEO
Hidetoshi Segi has been instrumental in steering Rohto Pharmaceutical Co., Ltd. through various phases of growth since taking the helm as CEO. With a background in pharmaceutical sciences and extensive experience in the industry, he has a proven track record of leading successful product launches and market expansions. Segi holds a degree in Pharmaceutical Sciences from a prestigious university and has previously held senior management positions within the company, contributing to its strategic direction and operational efficiency.
Track Record: Under Hidetoshi Segi's leadership, Rohto has successfully expanded its product lines and entered new markets, significantly increasing its global footprint. His strategic focus on innovation and quality has led to the development of several award-winning products in the eye care and personal care segments.
RPHCF OTC Market Information
The OTC Other tier includes companies that do not meet the criteria for higher tiers like the NYSE or NASDAQ. This tier often has less stringent reporting requirements, which can lead to a lack of transparency for investors. Companies in this tier may have lower trading volumes and less analyst coverage compared to those listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lower visibility and analyst coverage compared to major exchange-listed companies.
- Potential for higher volatility due to lower trading volumes.
- Limited regulatory scrutiny may lead to concerns about financial reporting accuracy.
- Increased risk of fraud or mismanagement in less regulated environments.
- Review recent financial statements and performance metrics.
- Examine the company's product pipeline and innovation strategy.
- Assess market conditions and competitive landscape.
- Verify the company's regulatory compliance and risk management practices.
- Evaluate management's track record and strategic vision.
- Established brand presence and history in the pharmaceutical industry.
- Positive consumer reviews and market reception of products.
- Transparency in financial reporting and communication with stakeholders.
What Investors Ask About Rohto Pharmaceutical Co.,Ltd. (RPHCF) — Consumer Defensive
What does Rohto Pharmaceutical Co.,Ltd. do?
Rohto Pharmaceutical Co., Ltd. manufactures and markets a wide range of pharmaceutical products, cosmetics, and functional foods. The company specializes in eye care products such as eye drops and contact lens solutions, as well as facial care items like cleansers and lotions. Rohto also offers internal medicines and dietary supplements, catering to diverse consumer needs globally.
What do analysts say about RPHCF stock?
Analysts generally view RPHCF as a stable player in the consumer defensive sector, with a focus on innovation and product quality. Key valuation metrics indicate a P/E ratio of 15.81 and a profit margin of 10.3%, suggesting a balanced approach to growth and profitability. Analysts are optimistic about Rohto's potential to expand its market share in emerging markets.
What are the main risks for RPHCF?
Rohto Pharmaceutical Co., Ltd. faces several risks, including regulatory challenges that could impact product approvals and sales. Additionally, fluctuations in raw material costs may affect production expenses, while intense competition from both established and new entrants poses a threat to market share. Changing consumer preferences may also require the company to adapt quickly to maintain its competitive edge.
What are the key factors to evaluate for RPHCF?
Rohto Pharmaceutical Co.,Ltd. (RPHCF) holds an AI score of 47/100 (low). Not financial advice.
How frequently does RPHCF data refresh on this page?
RPHCF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven RPHCF's recent stock price performance?
Rohto Pharmaceutical Co.,Ltd. (RPHCF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation and consumer trust in product quality. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider RPHCF overvalued or undervalued right now?
Valuing Rohto Pharmaceutical Co.,Ltd. (RPHCF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying RPHCF?
Before investing in Rohto Pharmaceutical Co.,Ltd. (RPHCF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on available financial and operational metrics as of March 2026.